Cancer Chemotherapy: A Nursing Process ApproachJones & Bartlett Learning, 2001 - 778 páginas This text for beginning and advanced oncology nurses integrates the nursing process, including nursing diagnosis, with the administration of cancer chemotherapeutic agents. Chapters in the first section review the history of chemotherapy and the role of the oncology nurse in chemotherapy research. T |
Índice
The Unique Role of the Nurse in Cancer Chemotherapy | 4 |
The Phases of Clinical Trials | 11 |
Conclusion | 20 |
The Cell Cycle and Its Importance | 27 |
Gemcitabine 345 | 30 |
Rationale of SingleAgent Therapy versus Combination Therapy | 39 |
New Frontiers of Chemotherapy | 47 |
Biological Response Modifiers | 60 |
6Mercaptopurine | 403 |
Mesna | 406 |
Methotrexate | 408 |
MethylCCNU | 413 |
Misonidazole | 416 |
Mitoguazone dihydrochloride | 418 |
Mitomycin | 422 |
Mitotane | 427 |
Production and Function | 71 |
Chemoprevention | 79 |
Potential Toxicities and Nursing Management | 89 |
Section B Nausea and Vomiting | 133 |
Pharmacology of Antiemetics | 143 |
Toxicity to Other Organ Systems | 149 |
Bibliography | 176 |
Standardized Nursing Care Plans | 187 |
Amifostine for injection | 196 |
Aminoglutethimide | 202 |
Androgens | 209 |
Aziridinylbenzaquinone | 215 |
Bleomycin sulfate | 221 |
Busulfan | 227 |
Capecitabine | 233 |
Carmustine | 240 |
Cisplatin | 248 |
Cyclophosphamide | 258 |
Cytarabine liposome injection | 267 |
Dactinomycin | 274 |
Daunorubicin hydrochloride | 280 |
Dexrazoxane for injection | 290 |
Doxorubicin hydrochloride | 300 |
Epirubicin hydrochloride | 306 |
Estramustine phosphate | 312 |
Etoposide | 320 |
Floxuridine | 326 |
Fludarabine phosphate | 332 |
Flutamide | 338 |
Goserelin acetate | 348 |
Hexamethylmelamine | 351 |
Hydroxyurea | 354 |
Idarubicin | 358 |
Idoxirene | 363 |
Irinotecan | 370 |
Lasparaginase | 373 |
Leucovorin calcium | 378 |
Letrozole | 380 |
Leuprolide acetate | 382 |
Levamisole hydrochloride | 384 |
Lomustine | 388 |
Mechlorethamine hydrochloride | 391 |
Melphalan | 398 |
Mitoxantrone | 430 |
Oxaliplatin | 434 |
Paclitaxel | 437 |
Pala | 444 |
Pentostatin | 447 |
Plicamycin | 451 |
with carmustine | 455 |
Procarbazine hydrochlorozide | 460 |
Progestational agents | 464 |
Raloxifene hydrochloride | 466 |
Streptozocin | 469 |
Suramin sodium | 473 |
Tamoxifen citrate | 477 |
Temozolomide | 480 |
Teniposide | 485 |
6Thioguanine | 490 |
Thiotepa | 493 |
Tretinoin | 496 |
Topotecan hydrochloride | 501 |
Toremifene citrate | 504 |
Trimetrexate | 506 |
Vincristine | 514 |
Vinorelbine | 524 |
| 530 | |
Pharmacodynamic Interactions | 542 |
Conclusion | 548 |
Bibliography | 556 |
Overview of Primary Types of Diseases | 562 |
Conclusion | 588 |
AgeRelated Drug Toxicities | 601 |
General Principles for Nursing Practice | 608 |
Extravasation Hypersensitivity and Anaphylaxis | 621 |
Hypersensitivity Reactions and Anaphylaxis | 633 |
| 641 | |
Vascular Access | 648 |
Additional Issues in Chemotherapy Administration | 655 |
Vascular Access DeviceRelated Complications | 661 |
Summary | 668 |
Work Areas | 676 |
Medical Surveillance | 690 |
NCI Common Toxicity Criteria | 697 |
Nomograms for Determination of BSA from Height | 761 |
Otras ediciones - Ver todo
Cancer Chemotherapy: A Nursing Process Approach Margaret Barton-Burke,Gail M. Wilkes,Karen Ingwersen Vista de fragmentos - 2001 |
Términos y frases comunes
alopecia Alteration anaphylaxis anemia antiemetics Assess pt baseline bleomycin blood bone marrow depression cancer Cancer Chemotherapy cardiac cell cycle Chapter chemotherapeutic agents chemotherapy cisplatin cyclophosphamide daunorubicin decreased diarrhea Discuss with MD DOSAGE/RANGE doxorubicin drug administration dyspnea Early s/s Encourage pt Encourage small excreted Expected Outcomes I. A. extravasation frequent feedings GM-CSF hair loss hepatic high-dose increased infection and bleeding infection or bleeding Instruct pt less than body MECHANISM OF ACTION medications METABOLISM methotrexate mg/m² minimize mucositis myelosuppression nausea nausea and vomiting Nursing Care Plan Nursing Diagnosis Nursing Interventions I. A. occur Oncology Nursing oral pain patients receiving platelet Potential prior to drug procarbazine Pt and significant pt to report Pt will maintain Pt will verbalize pulmonary reactions Refer to sec renal risk s/s of infection serum side effects stem cells stomatitis symptoms Teach pt therapy thrombocytopenia toxicity transplant treatment tumor urine vesicant vincristine vomiting Yasko